Ledger.Open graph →
SEC Form D · filed August 14, 2017

Aclaris Therapeutics, Inc

Offering
$12.5M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher Powala · MALVERN, PAExecAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirectorSunil K. Gottipati · Princeton, NJExecRichard A. Bierly · MALVERN, PADirectorRichard A. Bierly · MALVERN, PADirectorFrank Ruffo · MALVERN, PAExecKacy Rozelle · Los Angeles, CAExecStuart Shanler · MALVERN, PAExecChristopher Powala · Wayne, PAExecSteven A. Tullman · MALVERN, PADirectorChristopher A. Molineaux · Malvern, PADirectorSteven A. Tullman · MALVERN, PADirectorStanley R. Westreich · Germantown, MDExec · DirectorGregory A. Ellis · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗